UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 81

Sortiert nach

Using Continuous Glucose Monitoring in Clinical Practice

Clinical diabetes, 2020-12, Vol.38 (5), p.429-438

Miller, Eden M

2020

Link zum Volltext

Verfügbarkeit prüfen

Update on the Gut Microbiome for the Primary Care Clinician

The Journal of family practice, 2022-07, Vol.71 (6), p.S76-S81

Miller, Eden M

2022

Link zum Volltext

Verfügbarkeit prüfen

Common Questions on Continuous Glucose Monitoring in Primary Care

The Journal of family practice, 2022-07, Vol.71 (6), p.S11-S16

Miller, Eden M

2022

Link zum Volltext

Verfügbarkeit prüfen

Continuous Glucose Monitoring in Practice

The Journal of family practice, 2023-07, Vol.72 (6 Suppl), p.S13-S18

Miller, Eden M

2023

Link zum Volltext

Verfügbarkeit prüfen

Glucagon-Like Peptide 1 Receptor Agonists Have the Potential to Revolutionize the Attainment of Target A1C Levels in Type 2 Diabetes-So Why Is Their Uptake So Low?

Clinical diabetes, 2023-04, Vol.41 (2), p.226-238

2023

Link zum Volltext

Verfügbarkeit prüfen

Overview of the efficacy and safety of SGLT-2 inhibitors in type 2 diabetes mellitus

The Journal of family practice, 2017-02, Vol.66 (2), p.S5

Miller, Eden M

2017

Link zum Volltext

Verfügbarkeit prüfen

Role of Injectable Medications in Type 2 Diabetes Treatment

The Journal of family practice, 2017-10, Vol.66 (10), p.S4

Miller, Eden M

2017

Link zum Volltext

Verfügbarkeit prüfen

Role of the kidney in glucose homeostasis: implications for SGLT-2 inhibition in the treatment of type 2 diabetes mellitus

The Journal of family practice, 2017-02, Vol.66 (2), p.S3

Miller, Eden M

2017

Link zum Volltext

Verfügbarkeit prüfen

Individualizing treatment with SGLT-2 inhibitor therapy in type 2 diabetes mellitus

The Journal of family practice, 2017-02, Vol.66 (2), p.S13

Miller, Eden M

2017

Link zum Volltext

Verfügbarkeit prüfen

Basal insulin in primary care.(An Evolutionary Perspective on Basal Insulin in Diabetes Treatment)

The Journal of family practice, 2016-10, Vol.65 (10), p.S8

Miller, Eden M

2016

Link zum Volltext

Verfügbarkeit prüfen

Oral semaglutide in patients with type 2 diabetes and cardiovascular disease, renal impairment, or other comorbidities, and in older patients

Postgraduate medicine, 2020-10, Vol.132 (sup2), p.37-47

2020

Link zum Volltext

Verfügbarkeit prüfen

Treatment Intensification With Insulin Pumps and Other Technologies in Patients With Type 2 Diabetes: Results of a Physician Survey in the United States

Clinical diabetes, 2020-01, Vol.38 (1), p.47-55

2020

Link zum Volltext

Verfügbarkeit prüfen

Differentiating Among the SGLT-2 Inhibitors: Considering Cardiovascular and Other Safety Outcomes

The Journal of family practice, 2018-08, Vol.67 (8 suppl), p.S37-S42

2018

Link zum Volltext

Verfügbarkeit prüfen

Role of the kidney and SGLT-2 inhibition in type 2 diabetes mellitus

The Journal of family practice, 2015-12, Vol.64 (12), p.S54

2015

Link zum Volltext

Verfügbarkeit prüfen

Individualizing care with injectable glucose-lowering agents

The Journal of family practice, 2013-12, Vol.62 (12 Suppl CME), p.S12-S19

Miller, Eden M

2013

Link zum Volltext

Verfügbarkeit prüfen

Initiating insulin: How to help people with type 2 diabetes start and continue insulin successfully

International journal of clinical practice (Esher), 2017-08, Vol.71 (8), p.e12973-n/a

2017

Link zum Volltext

Verfügbarkeit prüfen

Addressing Unmet Needs With Injectable Medications in Type 2 Diabetes Treatment: Role of Injectable Medications in Type 2 Diabetes Treatment

The Journal of family practice, 2017-10, Vol.66 (10 Suppl), p.S4-S6

Miller, Eden M

2017

Link zum Volltext

Verfügbarkeit prüfen

Elements for Success in Managing Type 2 Diabetes With SGLT-2 Inhibitors: Role of the Kidney in Glucose Homeostasis: Implications for SGLT-2 Inhibition in the Treatment of Type 2 Diabetes Mellitus

The Journal of family practice, 2017-02, Vol.66 (2 Suppl), p.S3-S5

Miller, Eden M

2017

Link zum Volltext

Verfügbarkeit prüfen

Elements for Success in Managing Type 2 Diabetes With SGLT-2 Inhibitors: Overview of the Efficacy and Safety of SGLT-2 Inhibitors in Type 2 Diabetes Mellitus

The Journal of family practice, 2017-02, Vol.66 (2 Suppl), p.S5-S12

Miller, Eden M

2017

Link zum Volltext

Verfügbarkeit prüfen

Elements for Success in Managing Type 2 Diabetes With SGLT-2 Inhibitors: Individualizing Treatment With SGLT-2 Inhibitor Therapy in Type 2 Diabetes Mellitus

The Journal of family practice, 2017-02, Vol.66 (2 Suppl), p.S13-S16

Miller, Eden M

2017

Link zum Volltext

Verfügbarkeit prüfen

An Evolutionary Perspective on Basal Insulin in Diabetes Treatment: Basal Insulin in Primary Care

The Journal of family practice, 2016-10, Vol.65 (10 Suppl), p.S8-S13

Miller, Eden M

2016

Link zum Volltext

Verfügbarkeit prüfen

Hot Topics in Primary Care: Role of the Kidney and SGLT-2 Inhibition in Type 2 Diabetes Mellitus

The Journal of family practice, 2015-12, Vol.64 (12 Suppl), p.S54-S58

2015

Link zum Volltext

Verfügbarkeit prüfen

Overcoming Therapeutic Inertia: Practical Approaches.(CHAPTER 4)

The Journal of family practice, 2020-12, Vol.69 (10), p.S40

2020

Link zum Volltext

Verfügbarkeit prüfen

Introduction.(An Evolutionary Perspective on Basal Insulin in Diabetes Treatment)

The Journal of family practice, 2016-10, Vol.65 (10), p.S2

2016

Link zum Volltext

Verfügbarkeit prüfen

Introduction

The Journal of family practice, 2016-10, Vol.65 (10), p.S2

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 81

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(73)

Publikationsform

Sprache

Englisch
(81)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(47)
Life Sciences & Biomedicine
(41)
Humans
(40)
Female
(18)
Male
(17)
General & Internal Medicine
(16)
Middle Aged
(15)
Medicine, General & Internal
(14)
Aged
(13)
Adult
(12)
Primary Health Care
(12)
Risk Factors
(11)
Biological And Medical Sciences
(10)
Care And Treatment
(10)
Type 2 Diabetes
(10)
Aged, 80 And Over
(9)
Diabetes Mellitus, Type 2 - Drug Therapy
(9)
Hypoglycemic Agents - Therapeutic Use
(9)
Dosage And Administration
(8)
Medical Sciences
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Using Continuous Glucose Monitoring in Clinical Practice

Update on the Gut Microbiome for the Primary Care Clinician

Common Questions on Continuous Glucose Monitoring in Primary Care

Continuous Glucose Monitoring in Practice

Glucagon-Like Peptide 1 Receptor Agonists Have the Potential to Revolutionize the Attainment of Target A1C Levels in Type 2 Diabetes-So Why Is Their Uptake So Low?

Overview of the efficacy and safety of SGLT-2 inhibitors in type 2 diabetes mellitus

Role of Injectable Medications in Type 2 Diabetes Treatment

Role of the kidney in glucose homeostasis: implications for SGLT-2 inhibition in the treatment of type 2 diabetes mellitus

Individualizing treatment with SGLT-2 inhibitor therapy in type 2 diabetes mellitus

Basal insulin in primary care.(An Evolutionary Perspective on Basal Insulin in Diabetes Treatment)

Oral semaglutide in patients with type 2 diabetes and cardiovascular disease, renal impairment, or other comorbidities, and in older patients

Treatment Intensification With Insulin Pumps and Other Technologies in Patients With Type 2 Diabetes: Results of a Physician Survey in the United States

Differentiating Among the SGLT-2 Inhibitors: Considering Cardiovascular and Other Safety Outcomes

Role of the kidney and SGLT-2 inhibition in type 2 diabetes mellitus

Individualizing care with injectable glucose-lowering agents

Initiating insulin: How to help people with type 2 diabetes start and continue insulin successfully

Addressing Unmet Needs With Injectable Medications in Type 2 Diabetes Treatment: Role of Injectable Medications in Type 2 Diabetes Treatment

Elements for Success in Managing Type 2 Diabetes With SGLT-2 Inhibitors: Role of the Kidney in Glucose Homeostasis: Implications for SGLT-2 Inhibition in the Treatment of Type 2 Diabetes Mellitus

Elements for Success in Managing Type 2 Diabetes With SGLT-2 Inhibitors: Overview of the Efficacy and Safety of SGLT-2 Inhibitors in Type 2 Diabetes Mellitus

Elements for Success in Managing Type 2 Diabetes With SGLT-2 Inhibitors: Individualizing Treatment With SGLT-2 Inhibitor Therapy in Type 2 Diabetes Mellitus

An Evolutionary Perspective on Basal Insulin in Diabetes Treatment: Basal Insulin in Primary Care

Hot Topics in Primary Care: Role of the Kidney and SGLT-2 Inhibition in Type 2 Diabetes Mellitus

Overcoming Therapeutic Inertia: Practical Approaches.(CHAPTER 4)

Introduction.(An Evolutionary Perspective on Basal Insulin in Diabetes Treatment)

Introduction

Suchergebnisse filtern